Your browser doesn't support javascript.
loading
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study.
Muccini, Camilla; Gianotti, Nicola; Diotallevi, Sara; Lolatto, Riccardo; Spagnuolo, Vincenzo; Canetti, Diana; Bagaglio, Sabrina; Perez, Victoria Gordo; Clemente, Tommaso; Bottanelli, Martina; Candela, Caterina; Nozza, Silvia; Castagna, Antonella.
Afiliación
  • Muccini C; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Gianotti N; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Diotallevi S; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Lolatto R; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Spagnuolo V; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Canetti D; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Bagaglio S; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Perez VG; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Clemente T; Vita-Salute San Raffaele University, Milan, Italy.
  • Bottanelli M; Vita-Salute San Raffaele University, Milan, Italy.
  • Candela C; Vita-Salute San Raffaele University, Milan, Italy.
  • Nozza S; Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Castagna A; Vita-Salute San Raffaele University, Milan, Italy.
Open Forum Infect Dis ; 11(7): ofae326, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38962526
ABSTRACT

Background:

The aim of the study was to evaluate the 12-month cumulative probability of treatment discontinuation (TD) in people with human immunodeficiency virus (HIV; PWH) and a long exposure to antiretroviral therapy (ART) switching to long-acting cabotegravir and rilpivirine (CAB/RPV).

Methods:

SCohoLART is a single-center, prospective, cohort study designed to collect both samples and clinical data from PWH with virological suppression who switched to bimonthly long-acting CAB/RPV. TD occurred at switch to another regimen for any reason including virological failure (VF); VF was defined as HIV RNA levels ≥50 copies/mL at 2 consecutive measurements or a single HIV RNA level ≥1000 copies/mL. Results were reported as median (interquartile range [IQR]) or frequency (percentage). Cumulative probabilities of TD were estimated using Kaplan-Meier curves.

Results:

We evaluated 514 participants; 467 (90.9%) were male, and their median age (IQR) was 49 (40-56) years. At the time of switching, the median time from HIV diagnosis and the median duration of ART were 14.0 (IQR, 8.8-20.5) and 11.4 (7.9-17.4) years, respectively; before starting CAB/RPV, the median number of antiretroviral regimens was 3 (2-4). During a median study follow-up (IQR) of 13.1 (9.1-15.5) months, 52 PWH (10.1%) experienced TD, including 4 (0.8%) for VF. The 12-month cumulative probability of TD was 11% (95% confidence interval, 8%-14%). The main cause of TD was injection site reaction (15 participants [28.8%]).

Conclusions:

The 1-year cumulative probability of TD with long-acting CAB/RPV was quite low in this cohort of people with a median exposure to ART of 10 years, in whom injection site reaction was the leading cause of TD. VFs were rare during study follow-up.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos